Corporation
AbCellera Biologics Inc.
- Meetings this Parliament
- 71
- With MPs
- 4
- Since Nov 2021
- 162
- Active registrations
- 1
Most recent reported meeting: Sep 29, 2026.
Lobbying by AbCellera Biologics Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (corporation) In effect since Jun 9, 2026 Receives government funding
Filed by Carl Hansen, President
Lobbyists
- Andrew Booth · Chief Financial Officer
- Murray McCutcheon · VP Corporate Development
Institutions they may lobby: Employment and Social Development Canada (ESDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Defence (DND), National Research Council (NRC), Natural Resources Canada (NRCan), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC)
What they're lobbying on (1)Hide details
- Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.
Registration 945748-366216-21. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Carl Hansen · In-house (corporation)
- Jean-Francois Courtois · Executive Director, Innovation, Science and Economic Development Canada (ISED)
- Jean-Pierre Mizero · Manager, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Michael Hamm · Director of Policy, Veterans Affairs Canada (VAC)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Stephen Fuhr · Secretary of State, Defence Procurement, Public Services and Procurement Canada (PSPC)
- James Rourke · Policy and Operations Advisor, Public Services and Procurement Canada (PSPC)
- Jo-Ann Purcell · Senior Director, Finance Canada (FIN)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Jonathan Wilkinson · Member of Parliament, House of Commons
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Sachelle Magloire-Prosper · Director of Operations, Innovation, Science and Economic Development Canada (ISED)
- James Rothwell · Senior Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Sarah Lawley · Assistant Deputy Minister, Health Canada (HC)
- Andrew Munro · Senior Advisor, Health Canada (HC)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Alexis Conrad · Assistant Secretary to the Cabinet, Innovation, Science and Economic Development Canada (ISED)
- Sachelle Magloire-Prosper · Director of Operataions, Innovation, Science and Economic Development Canada (ISED)
- James Rothwell · Senior Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Nicolas Harper · Senior Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Jean-Francois Courtois · Executive Director, Innovation, Science and Economic Development Canada (ISED)
- Jean-Pierre Mizero · Manager, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Paul Eagan · Medical Consultant, National Defence (DND)
- Julie Nadeau · Medical Countermeasures Stock Coordinator, Public Health Agency of Canada (PHAC)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Mitch Davies · President, National Research Council (NRC)
- Lakshmi Krishnan · Vice-President Research, Life Sciences (NRC), National Research Council (NRC)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Maximilian Baylor · Department of Finance, Finance Canada (FIN)
- Manjeet Vinning · Regional Advisor - BC, Prime Minister's Office (PMO)
- Shane Baddeley · Director, Finance Canada (FIN)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Maude Lavoie · Associate Assistant Deputy Minister, Finance Canada (FIN)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Eric Sabourin · Senior Investment Analyst, Innovation, Science and Economic Development Canada (ISED)
- Alhadji Mamat · Manager Investment Operations, Innovation, Science and Economic Development Canada (ISED)
- Sean Letourneau · Manager, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- David McFarlane · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Mona Nemer · Chief Science Advisor, Innovation, Science and Economic Development Canada (ISED)
- Vanessa Sung · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Jaspinder Komal · Assistant Deputy Minister, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Amelie Gauthier-Beaupre · Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
- Krista Melville · Project Manager, National Research Council (NRC)
- Mike McCluskie · R&D Director, Immunobiology, National Research Council (NRC)
- Simon Lord-Dufour · Technical Officer, National Research Council (NRC)
and 1 moreShow fewer
- Ahn Tran · Associate Reserach Officer, National Research Council (NRC)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.